BENJAMIN KRETZMANN M.D. NPI 1881824399

NPI Information

  • NPI: 1881824399
  • Provider Name: BENJAMIN KRETZMANN, M.D.
  • Classification: Internal Medicine - 207RR0500X
  • Specialization: Rheumatology
  • Entity Type: Individual
  • PECOS Registration: Yes
  • Address: 8700 BEVERLY BLVD RM 5512
    LOS ANGELES, CA
    ZIP 90048
  • Phone: (310) 423-5161

Map and Directions

Get Directions

NPI Details

Benjamin Kretzmann, M.D. is a rheumatology internal medicine in Los Angeles, CA with 16 years of experience. The provider is an internist who treats diseases of joints, muscle, bones and tendons. This specialist diagnoses and treats arthritis, back pain, muscle strains, common athletic injuries and collagen diseases. Benjamin Kretzmann, M.D. NPI is 1881824399. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a male.

Education
Medical School: UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE
Graduation Year:2009

The provider's business location address is:

8700 BEVERLY BLVD RM 5512
LOS ANGELES, CA
ZIP 90048
Phone: (310) 423-5161

The NPI 1881824399 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

  • Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) (HCPCS:J0717)
  • Injection, denosumab, 1 mg (HCPCS:J0897)
  • Injection, golimumab, 1 mg, for intravenous use (HCPCS:J1602)
  • Injection, infliximab, excludes biosimilar, 10 mg (HCPCS:J1745)
  • Injection, triamcinolone acetonide, not otherwise specified, 10 mg (HCPCS:J3301)
  • Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
  • Insertion of needle into vein for collection of blood sample (HCPCS:36415)
  • Injection of drug or substance under skin or into muscle (HCPCS:96372)
  • Blood test, comprehensive group of blood chemicals (HCPCS:80053)
  • Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count (HCPCS:85025)
  • Red blood cell sedimentation rate, to detect inflammation, non-automated (HCPCS:85651)
  • Measurement c-reactive protein for detection of infection or inflammation (HCPCS:86140)
  • Measurement of antibody for assessment of autoimmune disorder, any method (HCPCS:86235)
  • Measurement of complement (immune system proteins), antigen, (HCPCS:86160)
  • Measurement of complement function (immune system proteins) (HCPCS:86161)
  • Infusion, normal saline solution, 250 cc (HCPCS:J7050)
  • Injection of additional new drug or substance into vein (HCPCS:96375)
  • Injection of drug or substance into vein (HCPCS:96374)
  • Infusion into a vein for therapy, prevention, or diagnosis, each additional hour (HCPCS:96366)
  • Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less (HCPCS:96365)
  • Established patient office or other outpatient visit, 40-54 minutes (HCPCS:99215)
  • Gammaglobulin (immune system protein) measurement (HCPCS:82784)
  • Vitamin d-3 level (HCPCS:82306)
  • Measure of severe acute respiratory syndrome coronavirus 2 (covid-19) antibody (HCPCS:86769)
  • Administration of chemotherapy into vein, each additional hour (HCPCS:96415)
  • Ferritin (blood protein) level (HCPCS:82728)
  • Iron level (HCPCS:83540)
  • Iron binding capacity (HCPCS:83550)
  • Measurement of substance using immunoassay technique (HCPCS:83520)
  • New patient office or other outpatient visit, 60-74 minutes (HCPCS:99205)
  • Established patient office or other outpatient visit, 10-19 minutes (HCPCS:99212)
  • Administration of chemotherapy into vein, 1 hour or less (HCPCS:96413)
  • Cyanocobalamin (vitamin b-12) level (HCPCS:82607)
  • Limited ultrasound scan of joint or other extremity structure lacking blood vessels (HCPCS:76882)
  • Parathormone (parathyroid hormone) level (HCPCS:83970)
  • Blood test, thyroid stimulating hormone (tsh) (HCPCS:84443)
  • Folic acid level, serum (HCPCS:82746)
  • Aspiration and/or injection of fluid large joint using ultrasound guidance (HCPCS:20611)
  • Injection, ketorolac tromethamine, per 15 mg (HCPCS:J1885)
  • Measurement of antibody for rheumatoid arthritis assessment (HCPCS:86200)
  • Rheumatoid factor level (HCPCS:86431)
  • Creatine kinase (cardiac enzyme) level, total (HCPCS:82550)
  • Telephone medical discussion with physician, 11-20 minutes (HCPCS:99442)
  • Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg (HCPCS:J3420)
  • Follow-up hospital inpatient care per day, typically 35 minutes (HCPCS:99233)
  • Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
  • X-ray of wrist, minimum of 3 views (HCPCS:73110)
  • X-ray of hand, minimum of 3 views (HCPCS:73130)
  • Infusion, normal saline solution, sterile (500 ml = 1 unit) (HCPCS:J7040)
  • Injection, zoledronic acid, 1 mg (HCPCS:J3489)
  • Screening test for autoimmune disorder (HCPCS:86038)
  • Tuberculosis test, enumeration of t-cells (HCPCS:86481)
  • Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle (HCPCS:96401)
  • Measurement of dna antibody, native or double stranded (HCPCS:86225)
  • Aspiration and/or injection of fluid from large joint (HCPCS:20610)
  • Injection of trigger points, 3 or more muscles (HCPCS:20553)
  • Initial hospital inpatient care per day, typically 70 minutes (HCPCS:99223)
  • Telephone medical discussion with physician, 5-10 minutes (HCPCS:99441)
  • Telephone medical discussion with physician, 21-30 minutes (HCPCS:99443)
  • Hyaluronan or derivative, gel-one, for intra-articular injection, per dose (HCPCS:J7326)
  • Dxa bone density measurement of hip, pelvis, spine (HCPCS:77080)
  • Antibody identification test for white blood cell antibodies (HCPCS:86021)
  • Hemoglobin a1c level, by device for home use (HCPCS:83037)
  • Uric acid level, blood (HCPCS:84550)

The enumeration date for this NPI number is 7/17/2009 and was last updated on 2/28/2022.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available:

No. Taxonomy Code Taxonomy Clasification Taxonomy Specialization License Number License State Primary
1207RR0500XInternal MedicineRheumatologyA116280CALIFORNIAYes

What is NPI?

NPI stands for National Provider Identifier. The NPI is a 10-digit identification number that is completely unique. The NPI number by itself does not contain any identifiable information such as a provider’s speciality or location. The NPI is assigned to individuals or organizacions for their lifespan and it is independent of key provider information type updates like a change of practices, location or speciality.

This page was last updated on: 3/30/2025

NPI Synchronization or Removal

All materials and services on this site are provided on an "as is" and "as available" basis without warranty of any kind. The NPI record is maintained by the National Plan & Provider Enumeration System (NPPES) and anyone may request this information and other NPPES health care provider data from HHS under The Freedom of Information Act (FOIA), Title 5 of the United States Code, section 552. To update the NPI records please contact the NPPES.